Previous Article | Next Article 
Molecular and Cellular Biology, August 1999, p. 5453-5465, Vol. 19, No. 8
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
The Gene for the Embryonic Stem Cell Coactivator
UTF1 Carries a Regulatory Element Which Selectively Interacts with
a Complex Composed of Oct-3/4 and Sox-2
Masazumi
Nishimoto,
Akiko
Fukushima,
Akihiko
Okuda, and
Masami
Muramatsu*
Department of Biochemistry, Saitama Medical
School, Iruma-gun, Saitama 350-0495, Japan
Received 16 February 1999/Returned for modification 30 March
1999/Accepted 4 May 1999
 |
ABSTRACT |
UTF1 is a transcriptional coactivator which has recently been
isolated and found to be expressed mainly in pluripotent embryonic stem
(ES) cells (A. Okuda, A. Fukushima, M. Nishimoto, et al., EMBO J. 17:2019-2032, 1998). To gain insight into the regulatory network of
gene expression in ES cells, we have characterized the regulatory
elements governing UTF1 gene expression. The results indicate that the
UTF1 gene is one of the target genes of an embryonic octamer binding
transcription factor, Oct-3/4. UTF1 expression is, like the FGF-4 gene,
regulated by the synergistic action of Oct-3/4 and another embryonic
factor, Sox-2, implying that the requirement for Sox-2 by Oct-3/4 is
not limited to the FGF-4 enhancer but is rather a general mechanism of
activation for Oct-3/4. Our biochemical analyses, however, also reveal
one distinct difference between these two regulatory elements: unlike
the FGF-4 enhancer, the UTF1 regulatory element can, by its one-base
difference from the canonical octamer-binding sequence, selectively
recruit the complex comprising Oct-3/4 and Sox-2 and preclude the
binding of the transcriptionally inactive complex containing Oct-1 or Oct-6. Furthermore, our analyses reveal that these properties are
dictated by the unique ability of the Oct-3/4 POU-homeodomain that
recognizes a variant of the Octamer motif in the UTF1 regulatory element.
 |
INTRODUCTION |
Understanding cell-type commitment
and differentiation at the molecular level is a major subject of
developmental biology. The first overt differentiation step occurs at
about 3.5 days postcoitum (d.p.c.) in murine development. At this time,
a blastocyst is formed which consists of two distinct cell lineages,
i.e., the trophectoderm and the inner cell mass (ICM). The former
generates a major part of the placenta and the extraembryonic yolk
sacs, whereas the latter can be differentiated into essentially any type of cells, including embryonic and extraembryonic tissues. Subsequently, an epithelial layer (primitive endoderm) appears on the
surface of the ICM at ca. 4.0 d.p.c., and the remaining compacted
core of ICM becomes a layer known as primitive ectoderm (for details,
see reference 13). Up until the later stages of gastrulation, primitive ectoderm is defined, by a number of criteria, as a pluripotent embryonic tissue from which both somatic and germ line
tissues are derived. For example, Gardner and Rossant (12)
demonstrated that, when a single primitive ectodermal cell was isolated
from a 4.5-d.p.c. embryo and injected into a 3.5-d.p.c. embryo of a
different genotype, the injected cell underwent normal embryonic
development and was found in all kinds of somatic tissues and germ
cells of the adult chimera mouse. Thus, understanding the pluripotent
properties of the primitive ectoderm at a molecular level is one of the
fundamental issues of early mammalian embryogensis. Embryonic carcinoma
(EC) cell lines, such as F9 and P19 cells, are widely used as a model
system for studying gene regulation during early developmental stages
of mammals, since EC cells share a number of properties with early
embryonic cells. Most significantly, these EC cells can be induced to
differentiate in vitro into a variety of cell types by using retinoic
acids and/or by aggregate formation, allowing systematic analyses of
gene regulation which governs and maintains the pluripotent state of
embryonic cells (29).
It is known that a number of transcription factors, including the HOX
gene family, are upregulated during differentiation of EC cells
(7, 23, 30). However, to understand the molecular basis of
maintenance of the pluripotent state of embryonic cells, it is
important to identify factors whose expression is restricted to
undifferentiated pluripotent EC cells and downregulated during differentiation of these cells. So far, only five transcription factors, i.e., Oct-3/4 (33, 39, 41), Oct-6 (43,
49), SOX-2 (48), PEA3 (46), and REX-1
(17, 38) have been shown to display such an expression
profile, and their expression is significantly decreased or even
extinguished when EC cells are induced to differentiate. In addition to
these factors, we have recently cloned a transcriptional coactivator
termed UTF1, whose expression is also rather restricted to embryonic
stem cells (34). Thus, these factors, including UTF1, may
well be involved in maintaining the pluripotent properties of early
embryonic cells and, for this reason, it is important to systematically
analyze their biochemical and biological properties. At the same time,
it is equally important to know how the expression of the genes
encoding these embryonic transcriptional factors or cofactors is
controlled, as such information may lead to the identification of novel
embryonic factors and/or uncover the regulatory hierarchy among these
embryonic stem cell factors. Ultimately, these studies may help to
unravel the broader aspects of a regulatory network operating in
pluripotent embryonic stem cells.
In this context, we have characterized the regulatory elements of the
UTF1 gene and found that this gene is under the control of Oct-3/4.
Interestingly, as in the case of the enhancer element of the FGF-4 gene
(1, 8, 48), UTF1 expression is regulated by a synergistic
action of Oct-3/4 and another embryonic factor, Sox-2, implying that
the requirement for Sox-2 to exert transcriptional stimulating activity
of Oct-3/4 is not limited to the FGF-4 enhancer but is rather a
widespread mode for Oct-3/4 to support target gene activation.
Moreover, we also demonstrate the unique property of the UTF1
regulatory element to selectively recruit the Sox-2/Oct-3/4 complex.
 |
MATERIALS AND METHODS |
DNA manipulations.
The sequence of the UTF1 genomic DNA from
a BALB/c mouse has been deposited in the GenBank data library under
accession number AB017360. The organization and restriction map of the
gene are shown in Fig. 1A. To construct the
UTF1 reporter gene, a 4.9-kb genomic BamHI DNA fragment carrying the UTF1 gene was
recovered and subcloned into pBluescript KS II(+). Subsequently,
single-stranded DNA was recovered with the aid of the helper phage, and
two KpnI sites were created at the positions of +158 and
+359 (the adenine nucleotide of the initiating methionine codon is set
to +1). To construct the 5' deletion mutants shown in Fig. 3B,
BamHI sites were created by site-directed mutagenesis
according to the manufacturer (Amersham) at the indicated positions,
and BamHI fragments bearing the
UTF1 gene were recovered
and subcloned into pBluescript KS II(+). To construct 3' deletion
mutants, single-stranded DNA was recovered by using 5' del-4 mutant as
described above, and BglII sites were created at the
indicated positions. Subsequently, appropriate DNA fragments were
removed, and the remaining portions, including the vector portion, were
self-ligated. However, to construct the 3' del-1 mutant, the
BamHI/BglII fragment carrying the
UTF1 gene was isolated and subcloned into pBluescript KS II(+). The mutant reporter genes shown in Fig. 4B were created by site-directed mutagenesis with single-stranded DNA derived from the 5' del-4 mutant.
Mutated sequences were as shown in the figure legend. The reporter
plasmid used in Fig. 4D and Fig. 9B bearing the consensus Octamer
sequence (5'-ATTAGCAT-3') was also generated by the
mutagenesis reaction. The expression vectors of Sox-2 and Oct-3/4
subcloned into pCEP4 (invitrogen) have been described by Yuan et al.
(48). The entire Oct-1 and Oct-6 cDNAs were also subcloned
into the pCEP4 expression vector. To construct Flag-tagged Oct-3/4 and Sox-2 expression vectors, the entire coding sequences of these cDNAs
were recovered by PCR as KpnI/BamHI fragments and
subcloned into pCEP4 vector together with the double-stranded
oligonucleotides bearing initiating methionine codon followed by the
Flag-tagged sequence. All chimeric protein expression vectors were made
by creating restriction sites at the desired junction points and subsequently joining the relevant restriction fragments. Although, in
certain cases, creation of each restriction enzyme site resulted in one
or two amino acid changes in the protein, we confirmed that these
mutations per se do not affect the intrinsic DNA binding properties of
the original proteins in terms of interacting with consensus Octamer
sequence and the wild-type UTF1 regulatory element (data not shown).
Cell culture and in vitro differentiation of ES cells.
P19
EC cells and HeLa cells were cultured as described by Okamoto et al.
(33) and Fukushima et al. (11), respectively. E14
ES cells (15) were cultured in the presence of
leukemia-inhibiting factor as described by Williams et al.
(45). Differentiation of embryonic stem (ES) cells was
induced by the formation of embryoid bodies by culturing the cells with
bacterial dishes in the absence of leukemia inhibitory factor for 4 days, and the embryoid bodies were replated to the tissue culture grade
plates to form monolayers of differentiated cells (for details, see
reference 37).
RNase mapping analyses.
To prepare the riboprobe for the
detection of transcripts from
UTF1 gene and endogenous UTF1 RNA, the
282-bp PCR fragment started from +62 was recovered by using
UTF1
gene as a template and subcloned into pBluescript KS II(+).
Radiolabeled antisense UTF1 RNA was produced by the standard method
according to the manufacturer (Promega) and hybridized with RNAs as
described previously (34). Since the riboprobe does not
carry the specific portion of exon 1 deleted in the
UTF1 gene, the
probe would not hybridize with endogenous UTF1 contiguously due to the
sequence not being present in the probe. Thus, RNase treatment with
such duplex-comprising probe and endogenous RNA results in the
generation of two short bands (186 and 96 bases) in the gel. For the
detection of the transcripts of the internal neomycin-resistant gene,
radiolabeled antisense RNA covering from 190 to 304 nucleotides of the
gene was used. For the detection of various mRNA species shown in Fig. 2, the following portions of the cDNAs, which appear to be unique in
sequences, were used: Sox-2 (48), nucleotides 480 to 905; Oct-3/4 (39), nucleotides 1 to 402; Oct-6 (43),
nucleotides 889 to 1359; GATA4 (2), nucleotides 1187 to
1560; and MyoD (36), nucleotides 1102 to 1425. The numbers
represent the position when the adenine nucleotide of the initiating
methionine codon is set to +1.
Gel shift analysis.
HeLa cells were transfected with the
indicated expression vectors as described previously (11),
and the whole-cell extracts were prepared after 48 h of
transfection according to the standard protocol (for details, see
reference 9). The gel shift analyses were performed
at room temperature for 20 min with 2 fmol of either one of the probes
shown in Fig. 5A or one carrying the consensus Octamer sequence. The
binding buffer contained 20 mM HEPES-KOH (pH 7.6), 1 mM EDTA, 1 mM
dithiothreitol, 2 mM MgCl2, 20% glycerol, and 50 mM NaCl.
The reaction mixture (20 µl) contained 1 to 4 µg of whole-cell
extract and 2 µg of sonicated salmon sperm DNA. However, 5 µg of
whole-cell extract was used for the analyses shown in Fig. 6C. In Fig.
7, 4 µg of nuclear extracts from undifferentiated and differentiated
P19 EC cells were used in the analyses. For the analysis shown in Fig.
6B, 0.1 µg of the specific antibody was also added. The reaction
mixture was loaded onto a 4% gel in 20 mM Tris-borate (pH 8.0)-0.5 mM
EDTA, which had been prerun at 16 V/cm for 1 h. The gels were
electrophoresed at the same voltage until the bromophenol blue dye
migrated to the bottom of the gel.
 |
RESULTS |
Regulatory region governing UTF1 gene expression in pluripotent
embryonic cells.
We have recently cloned the cDNA for a
transcriptional cofactor termed UTF1 by using genetic selection in
yeast cells. Biochemical analyses reveal that UTF1 has many of the
hallmark characteristics expected for a coactivator (34).
One of the interesting features of UTF1 is its unique expression
profile. UTF1 has been shown to be expressed in ES cells, as well as in
EC cells, and this expression is extinguished when these cells are
induced to differentiate. Furthermore, we have found that such
expression profile is also observed in human teratocarcinoma cell lines
(11). To identify the regulatory element(s) governing this
UTF1 expression pattern, we first isolated a chromosomal DNA fragment
carrying the UTF1 gene (32a; a physical map of part
of the obtained DNA is shown in Fig. 1A)
and examined whether any putative regulatory element(s) of the UTF1
gene are located in close proximity to the structural gene region.
Namely, we stably integrated a genomic DNA fragment, designated
UTF1
(Fig. 1A), into P19 EC cells and analyzed the levels of expression from
the introduced DNA by RNase mapping analysis.
UTF1 bears certain
portions of 5' (2.9 kb) and 3' (0.8 kb) flanking regions in addition to
the coding region of UTF1 gene, but it lacks a portion of exon 1. Therefore, the transcripts from
UTF1 can be distinguished from
endogenously expressed UTF1 RNA, allowing us to monitor the relative
levels of these two transcripts with a single probe (see Materials and
Methods for more details). As shown in Fig. 1B, lane 1, when P19 cells
were maintained in pluripotent states, transcripts from the
UTF1
gene and the endogenous UTF1 gene were detected. More importantly, both
types of RNA became undetectable when P19 cells were induced to
differentiate with the treatment of retinoic acid, although RNA was
produced from an internal control neomycin-resistant gene which is
under the control of the
-actin promoter (14) at
comparable levels irrespective of the undifferentiated or
differentiated state of the P19 cells (lane 2). Thus, these results
indicate that the regulatory element(s) supporting specific expression
of UTF1 in undifferentiated P19 cells are located within the introduced
DNA fragment.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 1.
The UTF1 gene carries the regulatory region(s) which
are responsible for the pluripotent-state-specific expression of UTF1
gene. (A) Structures of UTF1 genomic gene and the reporter gene
UTF1. The gene consists of two exons interrupted by a short intron
(97 bp). The exons are indicated as black boxes, and the portion of the
first exon is deleted in the reporter gene to distinguish between
exogenous and endogenous UTF1 RNAs. The shaded box indicates the region
used for generating radiolabeled antisense RNA. The restriction enzyme
sites are abbreviated as follows: B, BamHI; E,
EcoRI; H, HindIII; and S, SalI.
(B) The UTF1 reporter gene supports the expression in
undifferentiated P19 EC cells. P19 EC cells were transfected with
UTF1 gene, together with the neomycin-resistant gene which is under
the control of -actin promoter (14). After selection with
G418, ca. 1,000 of the drug-resistant colonies were pooled and
expanded. Subsequently, the cells were incubated with fresh medium
containing charcoal-treated serum supplemented with or without 1 µM
retinoic acid. After 48 h, RNA was recovered from such treated
cells, and the levels of transcripts from UTF1 and
neomycin-resistant genes, as well as endogenous UTF1 RNA, were
determined by the RNase mapping analyses as described in Materials and
Methods.
|
|
To confirm that

UTF1 also shows a similar expression profile in
other embryonic cells, we introduced the

UTF1 gene into
ES cells. ES
cells in which the transfected DNA was stably integrated
were subjected
to in vitro differentiation by forming simple embryoid
bodies as
described by Robertson (
37). As shown in Fig.
2, this
process was accompanied by the
extinction of transcripts from
exogenously introduced DNA, as well as
endogenous UTF1 transcripts,
confirming that the

UTF1 gene displays
an expression profile
equivalent to that of the endogenous gene in ES
cells. We also
examined the expression of other genes and confirmed
that the
Oct-3/4, Oct-6, and Sox-2 genes were downregulated, whereas
GATA4
and MyoD genes were markedly upregulated during this process,
verifying that differentiation signal is properly transduced in
the ES
cells. We also noted that levels of UTF1 transcripts decreased
faster
than those of Oct-3/4 and Sox-2, and we present these data
in more
detail in the Discussion.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 2.
The regulatory region(s) in UTF1 gene also work in ES
cells. The UTF1 gene was introduced into E14 ES cells by
electropolation, together with the neomycin-resistant gene. After the
selection of the cells in which UTF1 gene had been stably
integrated, these ES cells were subjected to in vitro differentiation
as described in Materials and Methods. During the course of this
procedure, RNA was recovered at the indicated days (0 to 20), and the
levels of specific RNA were determined by the RNase mapping analysis as
described in Materials and Methods.
|
|
To characterize the undifferentiated EC-cell-specific regulatory
elements in more detail, we made a series of deletion mutants
of

UTF1 DNA fragment (Fig.
3B). These
deletion mutants were transiently
transfected into P19 cells, and the
levels of transcripts from
these mutants were quantitated by RNase
mapping analysis as described
above. Four GC boxes are present in the
canonical promoter region
of the gene as shown in the sequence around
and upstream of the
initiating ATG codon (Fig.
3A), and the results
shown in Fig.
3B are consistent with the notion that these elements are
important
for driving the UTF1 expression. We did not obtain any
evidence
for the presence of additional regulatory elements in the 5'
flanking
region that act either positively or negatively to support the
unique expression profile of UTF1. We also noted that the 5' del-11
mutant (bp

65 to +2035), bearing no GC boxes, still produced
a low
level of transcripts. When 3' deletion mutants were characterized,
we
found that one particular mutant, 3' del-2 produced a significantly
lower level of transcripts than

UTF1, indicating that the region
deleted in this mutant contains important element(s) for sustaining
UTF1 expression in P19 EC cells. Interestingly, the activity level
supported by 3' del-2 was even lower than that obtained with 5'
del-11,
supporting the notion that the regulatory element(s) existing
in the 3'
flanking region is involved in elevating transcription
even from the 5'
del-11 reporter gene.

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 3.
Localization of regulatory regions governing UTF1
expression. (A) Nucleotide sequence around the initiating ATG codon.
Negative numbers indicate the nucleotide positions upstream of the
adenine nucleotide of the initiating methionine codon. GC boxes are
underlined. The oligo-capped method (28) revealed at least
15 transcription start sites downstream of the position of 56
(32b). (B) The UTF1 regulatory region is located in the 3'
flanking region of the gene. A series of 5' and 3' deletion mutants of
UTF1 gene was constructed as described in Materials and Methods.
Number of GC boxes present in each construct is shown. These mutants
were individually transfected with P19 EC cells, together with the
internal control neomycin gene, which is subcloned into pH Apr-1
vector (14), and RNA was recovered at 48 h
posttransfection. Subsequently, the levels of transcripts were
determined by RNase mapping analysis as described in Materials and
Methods. The intensity of the bands derived from the transcripts from
UTF1 or its derivatives and from the internal control gene was
determined by the Fuji-BAS2000 bioimaging analyzer (Fuji Film). The
ratio of these two different kinds of transcripts were calculated. The
average value obtained with UTF1 was arbitrarily set to 100%. The
data were obtained from five independent experiments with comparable
results.
|
|
UTF1 expression is regulated by two cis-active motifs:
the Octamer and the Sox binding elements.
Figure
4A shows the sequence of the 3' region
that is implicated in regulating UTF1 expression. We noted that there
are four potential cis-active elements, i.e., PEA3, Octamer,
Sox, and En-like binding sequences, although the Octamer and En-like
sequences are different from their consensus sequences. Interestingly,
each of these elements has been shown to bind embryonic stem cell
transcription factors. For example, a large number of Sry-related, Sox
motif binding factors have been identified (35) and one of
these, termed Sox-2, is expressed in EC cells (48).
Likewise, specific Octamer binding factors, Oct-3/4 and Oct-6, have
been shown to be expressed in embryonic stem cells and to play an
important role during early mammalian development (32, 33, 39, 41, 43, 49). Therefore, we mutated each element and examined whether the reporter gene expression was affected. As shown in Fig. 4C, little
or no effect was evident after mutation of the En-like or PEA3 motif.
In contrast, mutation of either the Octamer or Sox motif resulted in a
drastic decrease in the level of expression, indicating that both the
Octamer and Sox binding motifs are required for supporting UTF1
expression in P19 EC cells. Since the UTF1 regulatory element has an
atypical Octamer sequence, we examined whether conversion of this
variant sequence to the canonical Octamer sequence affected the level
of reporter gene expression. As shown in Fig. 4D, we found that this
nucleotide change did not affect the reporter gene expression. Thus,
these results indicate that the Octamer-like sequence in the UTF1
regulatory element is able to exert its function in a way equivalent to
that of the consensus sequence, although we do not have any evidence
that both the consensus and variant Octamer elements exert their
functions by interacting with the same transcription factors.




View larger version (91K):
[in this window]
[in a new window]
|
FIG. 4.
The UTF1 regulatory element is composed of Sox and
Octamer motifs. (A) Sequence of the UTF1 gene implicated in supporting
its expression in P19 EC cells. The potential transcription factor
binding sites are indicated as boldface letters with underlines. (B)
Schematic representation of four mutants carrying a mutation in one of
four potential transcription factor binding sites. In each mutant, the
sequence is mutated as follows: mtPEA (5'-AGGAAG-3' to
5'-ATGCAT-3'), mtOct (5'-ACTAGCAT-3' to
5'-ACGATCCT-3'), mtSOX (5'-AACAATG-3' to
5'-ACCCATT-3'), and mtEn (5'-AATTTACAAATTCT-3' to
5'-AATGTCCACATTCT-3'). (C) Both Octamer and Sox-binding
sites are required for UTF1 expression in P19 EC cells. The mutants
depicted in panel B were transiently introduced into P19 EC cells, and
the effect of these mutations was evaluated by analyzing the levels of
transcripts driven from these mutants by RNase mapping analysis as
described in Materials and Methods. The 3' del-2 mutant shown in Fig.
3B was also used for the study to see the level of transcription in the
absence of the regulatory element. (D) Conversion of the Octamer-like
sequence to the canonical site does not change the level of reporter
gene expression. The 5' del-4 reporter gene (WT) bearing the wild-type
UTF1 regulatory sequence and that bearing the consensus Octamer
sequence (Consensus) were transiently introduced into P19 EC cells and
compared to the levels of expression from these two reporter genes as
determined by RNase mapping analyses as described in Materials and
Methods.
|
|
Oct-3/4 displays a DNA binding specificity distinct from that of
Oct-1 or Oct-6 on the UTF1 regulatory element.
As the Octamer
factor-binding sequence found in the UTF1 regulatory region differs
from the consensus sequence, we examined whether the Octamer factors
are indeed able to bind to this divergent sequence. To this end, three
different Octamer factor expression vectors were individually
introduced into HeLa cells, and whole-cell extracts were prepared from
the transfected cells. Subsequently, the extracts were examined by
using gel shift analyses. As shown in Fig.
5B,
exogenously expressed Octamer factors
produced specific bands in the gel with the probe bearing the wild-type
UTF1 sequence but not with the mtOct probe, indicating that all three
factors can bind to the probe through the Octamer-like sequence. It is known that the Octamer sequence is essentially composed of two parts in
which the first four nucleotides (5'-ATTA/T-3') are recognized by the
POU-homeo domain of the Octamer factor and the remaining four
nucleotides (5'-GCAT-3') are recognized by the POU-specific domain
(16). To confirm that both units of the Octamer motif are
used for the binding of these Octamer factors, we extended the gel
shift analyses using mtOctH and mtOctS probes in which the 5' and 3'
halves of the Octamer sequence are mutated, respectively (Fig. 5A).
Although mtOctS probe did not serve as the binding site for any of the
Octamer factors, all three factors bound to mtOctH probe as efficiently
as to the wild-type UTF1 gene sequence. Thus, these results indicate
that these Octamer factors do not use the 5' half of the Octamer-like
sequence of the UTF1 regulatory sequence for their binding. It has been
shown that the relative positioning of the POU specific- and POU
homeodomains is rather flexible, allowing them to recognize fairly
diverse sequences and, in some cases, to adopt different orientations
or positions on the DNA (16). As one base mismatch resides
in the 5' half of the original UTF1 Octamer sequence and the mtOctH
mutation did not affect the binding of these Octamer factors to the
probe, we considered the possibility that the POU homeodomain does not utilize this part of the sequence but instead binds through an adenine
nucleotide-rich Sox binding sequence located at downstream of the
Octamer-like sequence. To examine this possibility, we performed a gel
shift analysis with the mtSox probe in which Sox-binding motif is
mutated. As shown in Fig. 5B, this mutation impaired the binding of
Oct-1 and Oct-6 to the probe. However, binding of Oct-3/4 to this
mutant DNA was not significantly affected. From these results, it
is assumed that all of the Octamer factors, including Oct-3/4,
bind to the regulatory region, as predicted above, by utilizing the Sox
site plus part of the Octamer-like sequence, i.e., 5'-GCAT-3'. However,
it appears that Oct-3/4 is also able to bind to the probe through the
Octamer-like sequence of the UTF1 gene without utilizing the Sox site.
Next, we performed the gel shift analyses with Sox-2 protein and found
that, as expected, the protein was able to bind to the mtOct probe, as
well as to the wild-type UTF1 sequence, but the binding to the mtSox
probe was abolished (Fig. 5C, left panel). We also performed the gel shift analyses with Oct-3/4 protein by using mtOctH and mtSox probes as
in Fig. 5B and applied them onto the gel side-by-side to compare the
mobilities of the protein-DNA complexes. These analyses revealed that
there is a slight difference in mobility between the complexes
generated with the mtOctH and mtSox probes (Fig. 5C, right panel).
Thus, these results indicate that there are indeed two modes of Oct-3/4
binding to the UTF1 regulatory element and support the conclusion
obtained with the analyses shown in Fig. 5A. Next, we decided to
determine the DNA sequence requirements of the Oct-6 POU homeodomain to
the Sox site by gel shift analyses by using mutant probes in which
either one of the nucleotides in the Sox site is mutated, as shown in
Fig. 5D. These analyses revealed that fourth and fifth adenine
nucleotides are crucial for the interaction with Oct-6 binding, while
most of other nucleotides, except for the seventh guanine nucleotide, also appears to be involved in the binding. Interestingly, mutation of
the third cytosine residue to an adenine residue decreased the
efficiency of the binding of Oct-6 to the probe. Thus, these results
indicate that, although the richness of AT nucleotides appears to be an
important factor, this is not the sole determinant. That is, it appears
that a certain specific sequence in the Sox site is also required for
the POU homeodomain to bind to the element.




View larger version (139K):
[in this window]
[in a new window]
|
FIG. 5.
Oct-3/4 displays a DNA binding specificity distinct from
Oct-1 and Oct-6. (A) Sequences used for the gel shift analyses. "X"
indicates the nucleotide which is different from that in the wild-type
UTF1 sequence. (B) Oct-3/4, but not Oct-1 or Oct-6, can bind through
the Octamer-like sequence of the UTF1 regulatory sequence. The Oct-1,
Oct-3/4, and Oct-6 expression vectors were individually introduced into
HeLa cells, and gel shift analyses were performed by using whole-cell
extracts prepared from such transfected cells as described in Materials
and Methods with either one of the probes shown in panel A. CONT,
extract prepared from HeLa cells which have been transfected with the
empty vector. (C) Binding modes of Sox-2 and Oct-3/4 to the UTF1
regulatory element. The whole-cell extracts were prepared from HeLa
cells which had been transfected with either Sox-2 or Oct-3/4
expression vector, and gel shift analyses were done as described in
Materials and Methods with the indicated probes. (D) DNA sequence
requirements of the Sox site for interaction with the POU homeodomain
of Oct-6. The Oct-6 expression vector was introduced into HeLa cells,
and whole-cell extracts were prepared from such transfected cells.
Subsequently, gel shift analyses were performed by using a series
mutant probes in which either one of nucleotides in the Sox site is
changed to the noncomplementary one (A C, G T). The efficiency of
the complex formation of these probes with Oct-6 was determined by
using the Fuji-BAS2000 bioimaging analyzer. The value obtained with the
wild-type sequence was arbitrarily set to 100%, and the relative
values obtained with different probes were calculated.
|
|
As it appears that Oct-1 and Oct-6 absolutely require the Sox-binding
sequence to bind to the probe, we reasoned that these
Octamer factors
might not be able to bind to the probe together
with Sox binding
factors such as Sox-2. To examine this possibility,
each of the Octamer
factors was expressed together with Sox-2,
and gel shift analyses were
performed by using extracts prepared
from the transfected cells. As
shown in Fig.
6A,
Sox-2 or Oct-3/4
alone each generated
specific bands in the gel (lanes 2 and 3).
However, when these proteins
were coexpressed, a novel band was
generated in addition to those
observed when each protein was
used alone (lane 4). It is probable that
this is due to the simultaneous
binding of Oct-3/4 and Sox-2 to the
probe, since the mobility
of this band is slower than those of the
bands generated by either
Oct-3/4 (lane 3) or Sox-2 (lane 2) alone. As
predicted, Sox-2
was not able to bind the probe together with Oct-6,
since no slow-migrating
band was generated in spite of the presence of
both Oct-6 and
Sox-2 proteins (lane 6). Analysis with cell extracts
prepared
from cells transfected with Oct-1 expression vector produced a
faint slowly migrating band, indicated by a star symbol, in the
presence of Sox-2 (lane 8). Further experiments revealed that
this is
indeed due to the simultaneous binding of Oct-1 and Sox-2
to the probe
(data not shown), indicating that Oct-1 may become
able to recognize
the Octamer-like sequence in the presence of
Sox-2, albeit very
inefficiently. Thus, these data suggest that
the ability of Oct-3/4 to
form a ternary complex with Sox-2 is
due to its ability to recognize
the Octamer-like sequence. To
further confirm this notion, we also
performed the gel shift analyses
with Oct-3/4 and Sox-2 by using mtOctH
probe. As Oct-3/4 binds
to this probe by utilizing the Sox site, we
reasoned that even
Oct-3/4 may not be able to bind to this mutant probe
together
with Sox-2. Consistent with this idea, Oct-3/4 and Sox-2 gave
rise to two distinct bands corresponding to independent binding
of
either one of these two proteins to mtOctH probe, and no evidence
of
the simultaneous binding of Oct-3/4 and Sox-2 on this probe
was
obtained (lane 12). Next, we performed experiments to confirm
that the
slowly migrating band reflected the simultaneous binding
of Oct-3/4 and
Sox-2 to the probe. To this end, we expressed the
wild-type Oct-3/4 and
a Flag-tagged Sox-2 protein in HeLa cells
(see Materials and Methods),
and the binding reaction, including
the whole-cell extract prepared
from the transfected cells, was
incubated with anti-Flag antibody
before electrophoresis. As shown
in Fig.
6B, left panel, the specific
antibody, but not the unrelated
anti-polyhistidine antibody, impaired
the generation of the slow-migrating
band, indicating that Sox-2 is
indeed involved in its formation.
Next, we expressed Oct-3/4 as a
Flag-tagged protein and found
that incubation of the extract with
anti-Flag-antibody impaired
the production of both fast- and
slow-migrating bands (Fig.
6B,
right panel). These results are
consistent with the notion that
the slow-migrating band reflects the
simultaneous binding of Oct-3/4
and Sox-2 to the probe. In Fig.
6A, we
have also demonstrated
that Sox-2 cannot bind simultaneously with
Oct-6, and we speculate
that this is because these Oct-6 and Sox-2
proteins compete with
each other for the same site (Sox-element) to
bind to the UTF1
regulatory element. To confirm this model, we extended
the gel
shift analyses as follows. Since Oct-6 and Sox-2 give specific
bands which comigrate in the gel, we have used chimera 1, which
is
depicted in Fig.
8A, instead of using the Oct-6 protein. This
chimera
has a complete POU DNA binding domain of Oct-6, but its
protein size is
much smaller than Sox-2, allowing it to separate
into two complexes
containing either chimera 1 or Sox-2 in the
gel. We performed gel shift
analysis with a constant amount of
chimera 1 and found that increasing
the amount of Sox-2 protein
in the reaction mixture resulted in a
decrease of the formation
of the probe/chimera 1 complex (Fig.
6C),
indicating that these
two proteins indeed bind to the UTF1 regulatory
element in a mutually
exclusive manner. We also performed gel shift
analyses by using
a probe in which the Octamer-like sequence was
converted to the
consensus sequence. As shown in Fig.
6D, all three
Octamer factors
appear to be able to bind efficiently to this probe
together with
Sox-2, indicating that the different properties of
Oct-3/4, Oct-1,
and Oct-6 only become evident when the nonconsensus
Octamer element
of the UTF1 gene is used. Figure
6E shows a model
illustrating
how the UTF1 regulatory element can specifically bind the
Sox-2/Oct-3/4
complex and preclude the simultaneous binding of Oct-6
(also true
for Oct-1) with Sox-2.


View larger version (60K):
[in this window]
[in a new window]
|
FIG. 6.
Gel shift analyses with Octamer factors and Sox-2
protein. (A) Oct-3/4, but not Oct-1 or Oct-6, can bind efficiently to
the UTF1 regulatory element together with Sox-2. Three Octamer factors
are individually expressed with or without Sox-2 expression, and gel
shift analyses were performed with whole-cell extracts prepared from
such transfected cells as described in Materials and Methods by using
wild-type (WT, left panel) or mtOctH (right panel) probe. The faint
band observed in lane 8, found to be generated due to the simultaneous
binding of Oct-1 and Sox-2, is indicated by a star. (B) Evidence of the
involvement of Oct-3/4 and Sox-2 in the formation of a slow-migrating
band. A HeLa whole-cell extract bearing both Oct-3/4 and Sox-2 proteins
in which either one of them is Flag-tagged was treated with anti-Flag
or anti-polyhistidine antibody, and a gel shift analysis was performed
with such antibody-treated extracts as described in Materials and
Methods. The arrowhead indicates the band generated due to the binding
of endogenous Oct-1 to the probe. (C) The Sox-2 and chimera 1 bearing
the POU DNA binding domain of Oct-6 bind to the UTF1 regulatory element
in a mutually exclusive manner. HeLa cells were transfected with
chimeric protein 1 (see Fig. 8A for the structure of the protein) or
Sox-2 expression vector, and whole-cell extracts were prepared from
such transfected cells. A constant amount (1 µg of protein) of
extract containing chimera 1 protein was mixed with variable amounts (0 to 4 µg) of Sox-2-containing extract, and gel shift analyses were
performed as described in Materials and Methods. The total amount of
extract in the reaction mixture was adjusted to 5 µg of protein by
using extract from HeLa cells which had been transfected with the empty
vector. (D) Both Oct-1 and Oct-6 became able to bind to the UTF1
regulatory element together with Sox-2 when the Octamer-like sequence
was converted to the consensus sequence. The same set of whole-cell
extracts used in panel A was used for the gel shift analyses by using
the probe in which an Octamer-like sequence is changed to the consensus
sequence. (E) Model showing how the UTF1 regulatory element can
selectively bind the complex comprising Oct-3/4 and Sox-2 and preclude
the binding of Oct-6 together with Sox-2.
|
|
As all of binding studies were done with HeLa cell extract with
overexpressed Oct and Sox proteins, we next examined whether
protein-DNA complexes similar to that observed in Fig.
6A are
also
generated with extracts from undifferentiated P19 EC cells.
As shown in
Fig.
7A, lane 1, four distinct bands were
obtained
with P19 EC cell extract. Next, we induced P19 EC cells to
differentiate
with retinoic acid and prepared the extract from such
differentiated
cells. Subsequently, gel shift analyses were performed.
It is
known that the expression of Oct-3/4 and Sox-2 is significantly
decreased or even extinguished during this differentiation process
(
33,
39,
48). We also found that the level of Oct-6
expression
is significantly attenuated during this process
(
32a). Therefore,
it is anticipated that most of the
complexes which are supposed
to contain at least either one of these
three proteins may not
be detected with extracts from such
differentiated P19 cells.
The results of the analyses are shown in Fig.
7A, lane 2. Consistent
with this idea, only one strong band, which is
supposed to correspond
to the probe complexed with Oct-1, was detected,
while signals
of the other three bands had disappeared or were
significantly
decreased. Thus, these results support the assumption
stated above
based on the mobility of the DNA-protein complexes. We
also performed
gel shift analyses with P19 EC cell extracts by using a
variety
of mutant probes. From the results obtained with the data shown
in Fig.
5B and Fig.
6A, it is anticipated that mtOct only binds
to
Sox-2, while mtSox probe only binds to Oct-3/4. However, mtOctH
probe
is supposed to be able to bind to all three Octamer factors
(Oct-1,
Oct-3/4, and Oct-6), as well as to Sox-2, although this
probe cannot
form ternary complex composed of Oct-3/4 and Sox-2.
The results are
shown in Fig.
7B. It was found that each probe
gave exactly the
expected pattern in the lane. Thus, these analyses
with mutant probes
further support the idea that factors which
were used in the analyses
shown in Fig.
6A are major factors present
in P19 EC cells which bind
to the UTF1 regulatory element.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 7.
Detection of factor(s) bound to the UTF1 regulatory
element in a P19 EC cell extract. (A) Gel shift analyses with
undifferentiated and differentiated P19 EC cell extracts. P19 EC cells
were either kept in pluripotent states or induced to differentiate with
1 µM retinoic acid for 48 h, and nuclear extracts were prepared
from such treated P19 cells. Subsequently, gel shift analyses were
performed as described in Materials and Methods. Each symbol represents
a specific DNA-protein complex. (B) Gel shift analyses with P19 EC cell
extract and a series of mutant probes. Gel shift analyses were
performed as described in Materials and Methods with nuclear extract
from undifferentiated P19 EC cell with either wild-type, mtOct, mtOctH,
or mtSox probe. From their mobilities, we assume that the
fastest-migrating band ( ) corresponds to probe complexed with
Oct-3/4, while the second one ( ) corresponds to the complex
containing Oct-6 or Sox-2. Likewise, third (*) and fourth ( ) bands
represent the ternary complex with Oct-3/4 and Sox-2 bound to the probe
and Oct-1/probe complex, respectively.
|
|
The POU-homeo domain of Oct-3/4 is crucial for its ability to bind
with Sox-2 on the UTF1 regulatory element.
To determine which
portion(s) of Oct-3/4 are critical for its ability to bind to the UTF1
regulatory element together with Sox-2, we made a series of chimeric
proteins between Oct-3/4 and Oct-6 (Fig.
8A) and compared their abilities to form
the ternary complex with Sox-2 on the UTF1 DNA probe. As shown in Fig.
8B, left panel, extracts containing chimera 1 or chimera 2 plus Sox-2 gave rise to two bands corresponding to independent binding of either
the Oct-chimera or the Sox-2 protein to the probe but no bands showed
the simultaneous binding of these two proteins. On the other hand,
chimera 3 containing the Oct-3/4 POU homeodomain produced a clear third
band with both the chimeric protein 3 and Sox-2. These results indicate
that the POU-specific domain of Oct-3/4 can be replaced by that of
Oct-6 but that the POU homeodomain is essential for the unique DNA
binding specificity of Oct-3/4. Analyses of additional chimeric
proteins (chimeras 4 to 6) further demonstrated that POU homeodomain of
Oct-3/4 is sufficient for conferring its unique DNA binding activity on
the chimeras (Fig. 8B, right panel). Experiments with specific antibody
revealed that Sox-2 is indeed involved in the formation of the
slow-migrating band (data not shown). We also found that all of the
chimeric proteins bound, together with Sox-2, on the probe bearing the consensus Octamer sequence (data not shown).

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 8.
The POU homeodomain is responsible for the different DNA
binding specificity between Oct-3/4 and Oct-6. (A) Schematic
representation of chimeric proteins between Oct-3/4 and Oct-6. The open
and shaded boxes represent the Oct-3/4 and Oct-6 portions,
respectively. The functional domains of the Octamer factor are
abbreviated as follows: AD, activation domain; S, POU-specific domain;
H, POU homeodomain; and L, linker portion. The expression vectors of
these chimeric proteins were constructed as described in Materials and
Methods. Chimeras 2, 3, 5, and 6 carry linker portion derived from that
of Oct-6. We also constructed a similar set of chimeras whose linker
portions are derived from that of Oct-3/4 (data not shown). However,
for an unknown reason, those chimeric proteins did not show any DNA
binding activity even on the consensus Octamer motif and, therefore,
could not be used for the subsequent analyses. However, analyses with
the six different chimeras depicted allowed us to conclude that the
unique DNA binding specificity of Oct-3/4 is defined by its POU
homeodomain (see below). (B) Gel shift analyses with the chimeric
protein and Sox-2. Whole-cell extracts were prepared from HeLa cells in
which chimeric protein expression vectors or corresponding empty vector
had been individually introduced with or without Sox-2 expression
vector. Whole-cell extracts were prepared at 48 h
posttransfection, and a gel shift analysis was then performed with the
extracts and the wild-type UTF1 element. The arrow indicates the band
generated due to the simultaneous binding of chimeric protein and Sox-2
on the probe. The complex generated by Sox-2 alone is indicated by a
single asterisk, while that generated by the chimeric protein is
indicated by two asterisks. However, in the right panel, the probe
complexed with Sox-2 and the probe complexed with one of the chimeric
proteins (4 to 6) could not be resolved in the gel due to the
similarity in the sizes of these proteins.
|
|
Functional interaction of the UTF1 regulatory element with the
Sox-2/Oct-3/4 complex.
In light of the above observations, we next
investigated whether the specific interaction of the UTF1 regulatory
element with the Sox-2/Oct-3/4 complex is also observed in vivo. For
this purpose, we introduced a reporter gene bearing wild-type UTF1
genomic sequence into HeLa cells together with Octamer factor and Sox-2
expression vectors by transient transfection. We also used certain
chimeras in this analysis to see whether these proteins also show the
expected DNA binding specificity in vivo. As shown in Fig.
9A, when the reporter gene (5' del-4)
bearing wild-type UTF1 sequence was used, an increasing amount of the
Sox-2 expression vector elevated the level of transcription from the
reporter gene significantly only when a constant amount of Oct-3/4
expression vector or chimera 3 bearing the same DNA binding specificity
as that of Oct-3/4 was cotransfected. However, no significant
activation was observed with Oct-6 or the chimera 2 protein. Thus,
these results indicate that Oct-3/4 and Sox-2 indeed bind to the UTF1
regulatory element simultaneously in vivo and that this ternary complex
could activate transcription of the reporter gene through this element.
Interestingly, chimera 5 bearing the same DNA binding specificity as
that of Oct-3/4 failed to activate reporter gene expression, indicating that the activation domains of Oct-3/4 also play an important role in
the synergistic activation of the reporter gene activation with Sox-2,
which is consistent with the previous conclusion obtained by Ambrosetti
et al. (1). To further substantiate these notions, we
extended these analyses by using a reporter gene whose Octamer-like sequence had been converted to the consensus Octamer sequence. These
analyses revealed that the chimeric protein 2, like the wild-type
Oct-3/4 and chimera 3, boosted the levels of transcription in concert
with Sox-2 (Fig. 9B). These results indicate that chimeric protein 2 is
intrinsically able to cooperate with Sox-2 to stimulate transcription,
and the failure of this protein to activate transcription through the
wild-type UTF1 sequence (Fig. 9A) is due to its inability to bind to
the DNA together with Sox-2. These results also demonstrate that Oct-6
and chimera 5 fail to activate transcription even when they are able to
bind the DNA together with Sox-2, further supporting the conclusion
given above that activation domains of Oct-3/4 are crucial in
activating reporter gene expression.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 9.
Cooperative function between Oct-3/4 and Sox-2 on the
UTF1 regulatory element. (A) Sox-2 is able to cooperate with Oct-3/4 on
the regulatory element of the UTF1 gene. HeLa cells were transfected
with a constant amount (4.0 µg) of Oct-3/4, Oct-6, or one of chimera
protein 2, 3, and 5 expression vectors, and the increasing amounts of
Sox-2 expression vector are as indicated. In addition, the 5' del-4
reporter gene (1.0 µg) and an internal control neomycin resistance
gene (0.5 µg) were also introduced. RNA was recovered at 48 h
posttransfection, and the transcripts from the reporter gene and those
from the internal control gene were detected by the RNase mapping
analyses as described in Materials and Methods. Subsequently, the
intensity of the bands corresponding to these two different kinds of
transcripts were determined as in Fig. 3B, and the ratio of these two
bands was calculated and presented. The data represent the average from
five independent experiments with comparative results. (B)
Transient-transfection analyses with the reporter gene, which has a
canonical Octamer sequence. The cotransfection experiments were done as
described above with the reporter gene in which the Octamer-like
sequence had been converted to the consensus sequence. The data were
obtained as in panel A.
|
|
 |
DISCUSSION |
It is known that transcription is uniquely regulated during early
mammalian embryogenesis (3, 10, 18, 22, 26, 27, 31). In this
study, we have characterized the regulatory region governing the
expression of the gene for the ES cell coactivator UTF1 in P19 EC
cells. The UTF1 gene regulatory region is composed of essentially two
transcription factor binding motifs, i.e., Octamer and Sox binding
sites. Furthermore, our data demonstrate that a specific Octamer
factor, Oct-3/4, is involved in supporting UTF1 expression in ES cells,
even though a number of other Octamer binding factors are present in
P19 cells and are coexpressed with UTF1 in early embryonic cells
(43, 49). It is also known that a number of proteins of the
Sox factor family can bind to the Sox motif (35). However,
since only one such factor, Sox-2, is assumed to be expressed in early
embryonic cells (48), this factor is the best candidate for
the Sox factor involved in the regulation of UTF1 expression in P19
cells. Consistent with this idea, our data demonstrate that Sox-2 is
involved in stimulation of transcription of the UTF1 gene by
cooperating with Oct-3/4. Both Oct-3/4 and Sox-2 are expressed in a
highly tissue-restricted manner, and the specific expression of Oct-3/4
during early embryonic stages as reported by Rosner et al.
(39) is indeed quite similar to that of UTF1, which we have
recently reported (34). Moreover, we have recently found
that UTF1 and Oct-3/4 are also coexpressed in primordial germ cells
(32a, 43, 47). Thus, these data are also consistent with the
notion that UTF1 acts downstream of Oct-3/4 in a regulatory cascade.
However, we noted that during the differentiation of ES cells, the
disappearance of UTF1 expression occurred earlier than that of Oct-3/4
or Sox-2 (Fig. 2). That is, by day 6 after the induction of
differentiation, UTF1 transcripts were almost undetectable, whereas
those for Oct-3/4 and Sox-2 were still present. Therefore, one may
consider that this result is not consistent with the idea that these
two transcription factors play a vital role in regulating UTF1
expression. Although we do not have any definitive answer to this
question at present, it is possible that the UTF1 regulatory element
requires rather high levels of Oct-3/4 and Sox-2 to exert its activity
and, therefore, the element is sensitive to the decrease in both
Oct-3/4 and Sox-2. Alternatively, downregulation of UTF1 expression may
result not only from the absence of Oct-3/4 and Sox-2 but also from an
additional gene-specific repression mechanism that becomes operative
upon EC cell differentiation.
There is a precedent for a regulatory element consisting of these
Octamer and Sox-binding motifs. Yuan et al. (48) have demonstrated that both Oct-3/4 and Sox-2 are crucial for the expression of the FGF-4 gene in EC cells. Therefore, it is anticipated that a
rather large number of downstream genes of Oct-3/4 are regulated in a
similar manner, since the fact that two embryonically expressed genes
contain similarly organized enhancers is probably not coincidental. It
is also noteworthy that a number of other proteins bearing a
high-mobility-group domain have been shown to interact with POU domain
proteins (1, 24, 50). Most significantly, it has recently
been shown that, in the brain, Sox-11, a distinct member of Sox family,
synergizes with POU domain-containing Brn-1 by the binding of both
proteins to adjacent DNA elements (21). Thus, these results
indicate that the combinatorial action between POU- and
Sox-domain-containing proteins occurs in numerous cell lineages and
that Oct-3/4 and Sox-2 play such a role in early embryonic cells. In
one case, Sox-2 has also been shown to negatively regulate Oct-3/4
activity on the regulatory region of the osteopontin gene
(5).
As discussed above, our analyses demonstrate a similarity in the
organization of the regulatory elements of the UTF1 and FGF-4 genes.
However, our data also reveal one significant difference between these
regulatory regions in the way in which they recruit the Sox-2/Oct-3/4
complex. It has been shown that the FGF-4 regulatory element can bind
not only Oct-3/4 but also Oct-1 together with Sox-2 (48). In
contrast, only Oct-3/4 can efficiently form the ternary complex with
Sox-2 on the UTF1 regulatory element. Our experiments further reveal
that this intrinsic difference is dictated by one base mismatch
existing in the 5' half of the Octamer-like sequence of the UTF1 gene.
This portion of the consensus Octamer motif is recognized by the POU
homeodomain of the Octamer factors (16). However, our data
demonstrate that the homeodomains of Oct-1 and Oct-6 are unable to
recognize the divergent UTF1 gene Octamer site because of this mutation
and instead utilize the adenine-rich Sox-binding motif for their
binding. Accordingly, as depicted in Fig. 6E, binding by these factors
covers the surface of nucleotides important for the interaction of
Sox-2 with the UTF1 regulatory element. In contrast, the POU
homeodomain of Oct-3/4 is able to recognize the nonconsensus Octamer
sequence and to allow Sox-2 binding to the adjacent Sox motif. It
therefore appears that Oct-3/4 displays a distinct activity from the
other Octamer binding proteins in its ability to bind to DNA together
with Sox-2 on the UTF1 element. It still remains to be determined how
the POU homeodomain of Oct-3/4 shows such an exquisite DNA binding specificity. The crystal structure of Oct-1 bound to DNA has shown that
critical contact is made between a specific amino acid (Asn-429) of
Oct-1 and the adenine nucleotide which base pairs with the second
thymine of the Octamer motif (5'-ATTA/TGCAT-3')
(19). Thus, it is possible that the absence of this
contact is responsible for the failure of Oct-1 to recognize the
Octamer-like sequence of the UTF1 gene. Therefore, the fact that
Oct-3/4 is able to bind to altered Octamer sequence may indicate that
it recognizes the motif in a way distinct from Oct-1. A number of
factors bearing the POU-DNA binding domain have been isolated and
classified into six different groups on the basis of sequence
homologies (44). Interestingly, Octamer factors used in this
study (Oct-1, Oct-3/4, and Oct-6) belong to distinct classes. Indeed,
amino acid sequences of POU homeodomains and POU-specific domains
of these three Octamer factors are rather significantly divergent and,
therefore, it is possible that nonconserved amino acids of the Oct-3/4
POU homeodomain are responsible for its unique DNA binding specificity.
In any event, it appears that the regulatory region of UTF1 has evolved in such a way to ensure pluripotent ES cell expression by the ability
to distinguish the transcriptionally active complex composed of Sox-2
and Oct-3/4 from transcriptionally inactive complexes containing Oct-1
or Oct-6.
The molecular basis of the pluripotent properties of ES cells is
largely unknown at present. However, one recent approach toward this
understanding is warranted. Gene-targeting analyses have clearly shown
the importance of Oct-3/4 gene and its target genes for sustaining the
early embryogenesis (32). For example, one of these target
genes, FGF-4, plays an important role at least in promoting
proliferation of trophectoderm precursors, and genetic knockout of this
gene results in an early embryonic lethal phenotype. So far, several
potential target genes of Oct-3/4, including the UTF1 gene, have been
identified (4, 5, 20, 25, 40, 48). In this context it is
noteworthy that two of them (FGF-4 and UTF1) are regulated in a similar
manner. It is, therefore, tempting to speculate that a substantial
number of other genes may also be subject to the synergistic action of
Oct-3/4 and Sox-2.
 |
ACKNOWLEDGMENTS |
We are indebted to Lisa Dailey, Hiroshi Hamada, and Winship Herr
for providing the Oct-3/4 plus Sox-2, the Oct-6, and the Oct-1
expression vectors, respectively. We also thank Hitoshi Niwa for
critical comments on this manuscript and Namiko Hihara for her
excellent technical assistance throughout this study.
This work was supported in part by the Ministry of Education, Science,
Sports, and Culture, Japan. A.O. was also supported by the Ministry of
Health and Welfare, Japan, and The Sankyo Foundation of Life Science.
A.F. is the recipient of a postdoctoral fellowship from the Japan
Health Science Foundation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biochemistry, Saitama Medical School, 38 Morohongo Moroyama, Iruma-gun, Saitama 350-0495, Japan. Phone: 81-492-76-1490. Fax: 81-492-94-9751. E-mail: MURAMATSU{at}SAITAMA-MED.AC.JP.
 |
REFERENCES |
| 1.
|
Ambrosetti, D. C.,
C. Basilico, and L. Dailey.
1997.
Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites.
Mol. Cell. Biol.
17:6321-6329[Abstract].
|
| 2.
|
Arceci, R. J.,
A. A. King,
M. C. Simon,
S. H. Orkin, and D. B. Wilson.
1993.
Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart.
Mol. Cell. Biol.
13:2235-2246[Abstract/Free Full Text].
|
| 3.
|
Bandara, L. R., and N. B. La Thangue.
1991.
Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor.
Nature
351:494-497[Medline].
|
| 4.
|
Ben-Shushan, E.,
J. R. Thompson,
L. J. Gudas, and Y. Bergman.
1998.
Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site.
Mol. Cell. Biol.
18:1866-1878[Abstract/Free Full Text].
|
| 5.
|
Botquin, V.,
H. Hess,
G. Fuhrmann,
C. Anastassiadis,
M. K. Gross,
G. Vriend, and H. R. Schöler.
1998.
New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2.
Genes Dev.
12:2073-2090[Abstract/Free Full Text].
|
| 6.
|
Brehm, A.,
K. Ohbo, and H. R. Schöler.
1997.
The carboxy-terminal domain of Oct-4 acquires cell specificity through the POU domain.
Mol. Cell. Biol.
17:154-162[Abstract].
|
| 7.
|
Colberg-Poley, A. M.,
S. D. Voss,
K. Chowdhury, and P. Gruss.
1985.
Structural analysis of murine genes containing homeo box sequences and their expression in embryonal carcinoma cells.
Nature
314:713-718[Medline].
|
| 8.
|
Dailey, L.,
H. Yuan, and C. Basilico.
1994.
Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer.
Mol. Cell. Biol.
14:7758-7769[Abstract/Free Full Text].
|
| 9.
|
Dent, C. L., and D. S. Latchman.
1993.
The DNA mobility shift assay, p. 1-26.
In
D. S. Latchman (ed.), Transcription factors. IRL Press, Oxford, United Kingdom.
|
| 10.
|
Dooley, T. P.,
M. Miranda,
N. C. Jones, and M. L. DePamphilis.
1989.
Transactivation of the adenovirus EIIa promoter in the absence of adenovirus E1A protein is restricted to mouse oocytes and preimplantation embryos.
Development
107:945-956[Abstract/Free Full Text].
|
| 11.
|
Fukushima, A.,
A. Okuda,
M. Nishimoto,
N. Seki,
T. Hori, and M. Muramatsu.
1998.
Characterization of functional domains of an embryonic stem cell coactivator UTF1 which are conserved and essential for potentiation of ATF-2 activity.
J. Biol. Chem.
273:25840-25849[Abstract/Free Full Text].
|
| 12.
|
Gardner, R. L., and J. Rossant.
1979.
Investigation of the fate of 4-5 day postcoitum mouse inner cell mass cells by blastocyst injection.
J. Embryol. Exp. Morphol.
52:141-152[Medline].
|
| 13.
|
Gilbert, S. F.
1997.
Developmental biology.
Sinauer Associates, Inc., Sunderland, Mass.
|
| 14.
|
Gunning, P.,
J. Leavitt,
G. Muscat,
S. Y. Ng, and L. Kedes.
1987.
A human beta-actin expression vector system directs high-level accumulation of antisense transcripts.
Proc. Natl. Acad. Sci. USA
84:4831-4835[Abstract/Free Full Text].
|
| 15.
|
Handyside, A. H.,
G. T. O'Neil,
M. Jones, and M. L. Hooper.
1989.
Use of BRL-conditioned medium in combination with feeder layers to isolate a diploid embryonal stem cell line.
Wilhelm Roux's Arch. Dev. Biol.
198:8-55.
|
| 16.
|
Herr, W., and M. A. Cleary.
1995.
The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain.
Genes Dev.
9:1679-1693[Free Full Text].
|
| 17.
|
Hosler, B. A.,
G. J. LaRosa,
J. F. Grippo, and L. J. Gudas.
1989.
An octamer motif contributes to the expression of the retinoic acid-regulated zinc finger gene Rex-1 (Zfp-42) in F9 teratocarcinoma cells.
Mol. Cell. Biol.
9:5623-5629[Abstract/Free Full Text].
|
| 18.
|
Imperiale, M. J.,
H. T. Kao,
L. T. Feldman,
J. R. Nevins, and S. Strickland.
1984.
Common control of the heat shock gene and early adenovirus genes: evidence for a cellular E1A-like activity.
Mol. Cell. Biol.
4:867-874[Abstract/Free Full Text].
|
| 19.
|
Klemm, J. D.,
M. A. Rould,
R. Aurora,
W. Herr, and C. O. Pabo.
1994.
Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules.
Cell
77:21-32[Medline].
|
| 20.
|
Kraft, H. J.,
S. Mosselman,
H. A. Smits,
P. Hohenstein,
E. Piek,
Q. Chen,
K. Artzt, and E. J. van Zoelen.
1996.
Oct-4 regulates alternative platelet-derived growth factor alpha receptor gene promoter in human embryonal carcinoma cells.
J. Biol. Chem.
271:12873-12878[Abstract/Free Full Text].
|
| 21.
|
Kuhlbrodt, K.,
B. Herbarth,
E. Sock,
J. Enderich,
I. Hermans-Borgmeyer, and M. Wegner.
1998.
Cooperative function of POU proteins and SOX proteins in glial cells.
J. Biol. Chem.
273:16050-16057[Abstract/Free Full Text].
|
| 22.
|
La Thangue, N. B., and P. W. J. Rigby.
1987.
An adenovirus E1A-like transcription factor is regulated during the differentiation of murine embryonal carcinoma stem cells.
Cell
49:507-513[Medline].
|
| 23.
|
LaRosa, G. J., and L. J. Gudas.
1988.
An early effect of retinoic acid: cloning of an mRNA (Era-1) exhibiting rapid and protein synthesis-independent induction during teratocarcinoma stem cell differentiation.
Proc. Natl. Acad. Sci. USA
85:329-333[Abstract/Free Full Text].
|
| 24.
|
Leger, H.,
E. Sock,
K. Renner,
F. Grummt, and M. Wegner.
1995.
Functional interaction between the POU domain protein Tst-1/Oct-6 and the high mobility-group protein HMG-I/Y.
Mol. Cell. Biol.
15:3738-3747[Abstract].
|
| 25.
|
Liu, L., and R. M. Roberts.
1996.
Silencing of the gene for the beta subunit of human gonadotropin by the embryonic transcription factor Oct 3/4.
J. Biol. Chem.
271:16683-16689[Abstract/Free Full Text].
|
| 26.
|
Majumder, S., and M. L. DePamphilis.
1995.
A unique role for enhancers is revealed during early mouse development.
Bioessays
17:879-889[Medline].
|
| 27.
|
Majumder, S.,
Z. Zhao,
K. Kaneko, and M. L. DePamphilis.
1997.
Developmental acquisition of enhancer function requires coactivator activity.
EMBO J.
16:1721-1731[Medline].
|
| 28.
|
Maruyama, K., and S. Sugano.
1994.
Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.
Gene
138:171-174[Medline].
|
| 29.
|
Martin, G. R.
1981.
Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells.
Proc. Natl. Acad. Sci. USA
78:7634-7638[Abstract/Free Full Text].
|
| 30.
|
Murphy, S. P.,
J. Garbern,
W. F. Odenwald,
R. A. Lazzarini, and E. Linney.
1988.
Differential expression of the homeobox gene Hox-1.3 in F9 embryonal carcinoma cells.
Proc. Natl. Acad. Sci. USA
85:5587-5591[Abstract/Free Full Text].
|
| 31.
|
Murray, E. J.,
D. Stott, and P. W. J. Rigby.
1991.
Sequences and factors required for the F9 embryonal carcinoma stem cell E1a-like activity.
Mol. Cell. Biol.
11:5534-5540[Abstract/Free Full Text].
|
| 32.
|
Nichols, J.,
B. Zevnik,
K. Anastassiadis,
H. Niwa,
D. Klewe-Nebenius,
I. Chambers,
H. R. Schöler, and A. Smith.
1998.
Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct-4.
Cell
95:379-391[Medline].
|
| 32a.
| Nishimoto, M., and M. Muramatsu. Unpublished data.
|
| 32b.
| Nishimoto, M., Y. Suzuki, S. Sugano, and M. Muramatsu. Unpublished data.
|
| 33.
|
Okamoto, K.,
H. Okazawa,
A. Okuda,
M. Sakai,
M. Muramatsu, and H. Hamada.
1990.
A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells.
Cell
60:461-472[Medline].
|
| 34.
|
Okuda, A.,
A. Fukushima,
M. Nishimoto,
A. Orimo,
T. Yamagishi,
Y. Nabeshima,
M. Kuro-o,
Y. Nabeshima,
K. Boon,
M. Keaveney,
H. G. Stunnenberg, and M. Muramatsu.
1998.
UTF1, a novel transcriptional coactivator expressed in pluripotent embryonic stem cells and extra-embryonic cells.
EMBO J.
17:2019-2032[Medline].
|
| 35.
|
Pevny, L. H., and R. Lovell-Badge.
1997.
Sox genes find their feet.
Curr. Opin. Genet. Dev.
7:338-344[Medline].
|
| 36.
|
Pinney, D. F.,
S. H. Pearson-White,
S. F. Konieczny,
K. E. Latham, and C. P. Emerson, Jr.
1988.
Myogenic lineage determination and differentiation: evidence for a regulatory gene pathway.
Cell
53:781-793[Medline].
|
| 37.
|
Robertson, E. J.
1987.
Embryo-derived stem cell lines, p. 71-112.
In
E. J. Robertson (ed.), Teratocarcinoma and embryonic stem cell. IRL Press, Oxford, United Kingdom.
|
| 38.
|
Rogers, M. B.,
B. A. Hosler, and L. J. Gudas.
1991.
Specific expression of a retinoic acid-regulated, zinc-finger gene, Rex-1, in preimplantation embryos, trophoblast and spermatocytes.
Development
113:815-824[Abstract].
|
| 39.
|
Rosner, M. H.,
M. A. Vigano,
K. Ozato,
P. M. Timmons,
F. Poirier,
P. W. J. Rigby, and L. M. Staudt.
1990.
A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo.
Nature
345:686-692[Medline].
|
| 40.
|
Saijoh, Y.,
H. Fujii,
M. Meno,
M. Sato,
Y. Hirota,
S. Nagamitsu,
M. Ikeda, and H. Hamada.
1996.
Identification of putative downstream genes of Oct-3, a pluripotent cell-specific transcription factor.
Genes Cells
1:239-252[Abstract].
|
| 41.
|
Schöler, H. R.,
S. Ruppert,
N. Suzuki,
K. Chowdhury, and P. Gruss.
1990.
New type of POU domain in germ line-specific protein Oct-4.
Nature
344:435-439[Medline].
|
| 42.
|
Schöler, H. R.,
T. Cicsiolka, and P. Gruss.
1991.
A nexus between Oct-4 and E1A: implications for gene regulation in embryonic stem cells.
Cell
66:291-304[Medline].
|
| 43.
|
Suzuki, N.,
H. Rohdewohld,
T. Neuman,
P. Gruss, and H. R. Schöler.
1990.
Oct-6: a POU transcription factor expressed in embryonal stem cells and in the developing brain.
EMBO J.
9:3723-3732[Medline].
|
| 44.
|
Verrijzer, C. P., and P. C. Van der Vliet.
1993.
POU domain transcription factors.
Biochim. Biophys. Acta
1173:1-21[Medline].
|
| 45.
|
Williams, R. L.,
D. J. Hilton,
S. Pease,
T. A. Willson,
C. L. Stewart,
D. P. Gearing,
E. F. Wagner,
D. Metcalf,
N. A. Nicola, and N. M. Gough.
1988.
Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells.
Nature
336:684-687[Medline].
|
| 46.
|
Xin, J. H.,
A. Cowie,
P. Lachance, and J. A. Hassell.
1992.
Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells.
Genes Dev.
6:481-496[Abstract/Free Full Text].
|
| 47.
|
Yoam, Y. I.,
G. Fuhrmann,
C. E. Ovitt,
A. Brehm,
K. Ohbo,
M. Gross,
K. Hübner, and H. R. Schöler.
1996.
Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells.
Development
122:881-894[Abstract].
|
| 48.
|
Yuan, H.,
N. Corbi,
C. Basilico, and L. Dailey.
1995.
Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3.
Genes Dev.
9:2635-2645[Abstract/Free Full Text].
|
| 49.
|
Zwart, R.,
L. Broos,
G. Grosveld, and D. Meijer.
1996.
The restricted expression pattern of the POU factor Oct-6 during early development of the mouse nervous system.
Mech. Dev.
54:185-194[Medline].
|
| 50.
|
Zwilling, S.,
H. Konig, and T. Wirth.
1995.
High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors.
EMBO J.
14:1198-1208[Medline].
|
Molecular and Cellular Biology, August 1999, p. 5453-5465, Vol. 19, No. 8
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Gao, F., Kwon, S. W., Zhao, Y., Jin, Y.
(2009). PARP1 Poly(ADP-ribosyl)ates Sox2 to Control Sox2 Protein Levels and FGF4 Expression during Embryonic Stem Cell Differentiation. J. Biol. Chem.
284: 22263-22273
[Abstract]
[Full Text]
-
Greer Card, D. A., Hebbar, P. B., Li, L., Trotter, K. W., Komatsu, Y., Mishina, Y., Archer, T. K.
(2008). Oct4/Sox2-Regulated miR-302 Targets Cyclin D1 in Human Embryonic Stem Cells. Mol. Cell. Biol.
28: 6426-6438
[Abstract]
[Full Text]
-
Xie, D., Cai, J., Chia, N.-Y., Ng, H. H., Zhong, S.
(2008). Cross-species de novo identification of cis-regulatory modules with GibbsModule: Application to gene regulation in embryonic stem cells. Genome Res
18: 1325-1335
[Abstract]
[Full Text]
-
van Bragt, M. P A, Roepers-Gajadien, H. L, Korver, C. M, Bogerd, J., Okuda, A., Eggen, B. J L, de Rooij, D. G, van Pelt, A. M M
(2008). Expression of the pluripotency marker UTF1 is restricted to a subpopulation of early A spermatogonia in rat testis. Reproduction
136: 33-40
[Abstract]
[Full Text]
-
Yaragatti, M., Basilico, C., Dailey, L.
(2008). Identification of active transcriptional regulatory modules by the functional assay of DNA from nucleosome-free regions. Genome Res
18: 930-938
[Abstract]
[Full Text]
-
Kimber, S J, Sneddon, S F, Bloor, D J, El-Bareg, A M, Hawkhead, J A, Metcalfe, A D, Houghton, F D, Leese, H J, Rutherford, A, Lieberman, B A, Brison, D R
(2008). Expression of genes involved in early cell fate decisions in human embryos and their regulation by growth factors. Reproduction
135: 635-647
[Abstract]
[Full Text]
-
Perrett, R. M., Turnpenny, L., Eckert, J. J., O'Shea, M., Sonne, S. B., Cameron, I. T., Wilson, D. I., Meyts, E. R.-D., Hanley, N. A.
(2008). The Early Human Germ Cell Lineage Does Not Express SOX2 During In Vivo Development or upon In Vitro Culture. Biol. Reprod.
78: 852-858
[Abstract]
[Full Text]
-
Kristensen, D. M., Nielsen, J. E., Skakkebaek, N. E., Graem, N., Jacobsen, G. K., Meyts, E. R.-D., Leffers, H.
(2008). Presumed pluripotency markers UTF-1 and REX-1 are expressed in human adult testes and germ cell neoplasms. Hum Reprod
23: 775-782
[Abstract]
[Full Text]
-
Williamson, A. J. K., Smith, D. L., Blinco, D., Unwin, R. D., Pearson, S., Wilson, C., Miller, C., Lancashire, L., Lacaud, G., Kouskoff, V., Whetton, A. D.
(2008). Quantitative Proteomics Analysis Demonstrates Post-transcriptional Regulation of Embryonic Stem Cell Differentiation to Hematopoiesis. Mol. Cell. Proteomics
7: 459-472
[Abstract]
[Full Text]
-
Zhou, Q., Chipperfield, H., Melton, D. A., Wong, W. H.
(2007). A gene regulatory network in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA
104: 16438-16443
[Abstract]
[Full Text]
-
Lavial, F., Acloque, H., Bertocchini, F., MacLeod, D. J., Boast, S., Bachelard, E., Montillet, G., Thenot, S., Sang, H. M., Stern, C. D., Samarut, J., Pain, B.
(2007). The Oct4 homologue PouV and Nanog regulate pluripotency in chicken embryonic stem cells. Development
134: 3549-3563
[Abstract]
[Full Text]
-
Tan, S. M., Wang, S. T., Hentze, H., Droge, P.
(2007). A UTF1-based selection system for stable homogeneously pluripotent human embryonic stem cell cultures. Nucleic Acids Res
35: e118-e118
[Abstract]
[Full Text]
-
van den Boom, V., Kooistra, S. M., Boesjes, M., Geverts, B., Houtsmuller, A. B., Monzen, K., Komuro, I., Essers, J., Drenth-Diephuis, L. J., Eggen, B. J.L.
(2007). UTF1 is a chromatin-associated protein involved in ES cell differentiation. JCB
178: 913-924
[Abstract]
[Full Text]
-
Wang, Z.-X., Teh, C. H.-L., Kueh, J. L. L., Lufkin, T., Robson, P., Stanton, L. W.
(2007). Oct4 and Sox2 Directly Regulate Expression of Another Pluripotency Transcription Factor, Zfp206, in Embryonic Stem Cells. J. Biol. Chem.
282: 12822-12830
[Abstract]
[Full Text]
-
Boer, B., Kopp, J., Mallanna, S., Desler, M., Chakravarthy, H., Wilder, P. J., Bernadt, C., Rizzino, A.
(2007). Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes. Nucleic Acids Res
0: gkm059v2-14
[Abstract]
[Full Text]
-
Niwa, H.
(2007). How is pluripotency determined and maintained?. Development
134: 635-646
[Abstract]
[Full Text]
-
Ji, H., Vokes, S. A., Wong, W. H.
(2006). A comparative analysis of genome-wide chromatin immunoprecipitation data for mammalian transcription factors. Nucleic Acids Res
34: e146-e146
[Abstract]
[Full Text]
-
Pereira, L., Yi, F., Merrill, B. J.
(2006). Repression of Nanog Gene Transcription by Tcf3 Limits Embryonic Stem Cell Self-Renewal. Mol. Cell. Biol.
26: 7479-7491
[Abstract]
[Full Text]
-
Nakatake, Y., Fukui, N., Iwamatsu, Y., Masui, S., Takahashi, K., Yagi, R., Yagi, K., Miyazaki, J.-i., Matoba, R., Ko, M. S. H., Niwa, H.
(2006). Klf4 Cooperates with Oct3/4 and Sox2 To Activate the Lefty1 Core Promoter in Embryonic Stem Cells. Mol. Cell. Biol.
26: 7772-7782
[Abstract]
[Full Text]
-
Sakaguchi, T., Nishimoto, M., Miyagi, S., Iwama, A., Morita, Y., Iwamori, N., Nakauchi, H., Kiyonari, H., Muramatsu, M., Okuda, A.
(2006). Putative "Stemness" Gene Jam-B Is Not Required for Maintenance of Stem Cell State in Embryonic, Neural, or Hematopoietic Stem Cells.. Mol. Cell. Biol.
26: 6557-6570
[Abstract]
[Full Text]
-
Wilson, M. E., Yang, K. Y., Kalousova, A., Lau, J., Kosaka, Y., Lynn, F. C., Wang, J., Mrejen, C., Episkopou, V., Clevers, H. C., German, M. S.
(2005). The HMG Box Transcription Factor Sox4 Contributes to the Development of the Endocrine Pancreas. Diabetes
54: 3402-3409
[Abstract]
[Full Text]
-
Taranger, C. K., Noer, A., Sorensen, A. L., Hakelien, A.-M., Boquest, A. C., Collas, P.
(2005). Induction of Dedifferentiation, Genomewide Transcriptional Programming, and Epigenetic Reprogramming by Extracts of Carcinoma and Embryonic Stem Cells. Mol. Biol. Cell
16: 5719-5735
[Abstract]
[Full Text]
-
Smith, A. E. F., Ford, K. G.
(2005). Use of altered-specificity binding Oct-4 suggests an absence of pluripotent cell-specific cofactor usage. Nucleic Acids Res
33: 6011-6023
[Abstract]
[Full Text]
-
Chew, J.-L., Loh, Y.-H., Zhang, W., Chen, X., Tam, W.-L., Yeap, L.-S., Li, P., Ang, Y.-S., Lim, B., Robson, P., Ng, H.-H.
(2005). Reciprocal Transcriptional Regulation of Pou5f1 and Sox2 via the Oct4/Sox2 Complex in Embryonic Stem Cells. Mol. Cell. Biol.
25: 6031-6046
[Abstract]
[Full Text]
-
Maruyama, M., Ichisaka, T., Nakagawa, M., Yamanaka, S.
(2005). Differential Roles for Sox15 and Sox2 in Transcriptional Control in Mouse Embryonic Stem Cells. J. Biol. Chem.
280: 24371-24379
[Abstract]
[Full Text]
-
Rodda, D. J., Chew, J.-L., Lim, L.-H., Loh, Y.-H., Wang, B., Ng, H.-H., Robson, P.
(2005). Transcriptional Regulation of Nanog by OCT4 and SOX2. J. Biol. Chem.
280: 24731-24737
[Abstract]
[Full Text]
-
Gu, P., Goodwin, B., Chung, A. C.-K., Xu, X., Wheeler, D. A., Price, R. R., Galardi, C., Peng, L., Latour, A. M., Koller, B. H., Gossen, J., Kliewer, S. A., Cooney, A. J.
(2005). Orphan Nuclear Receptor LRH-1 Is Required To Maintain Oct4 Expression at the Epiblast Stage of Embryonic Development. Mol. Cell. Biol.
25: 3492-3505
[Abstract]
[Full Text]
-
Kuroda, T., Tada, M., Kubota, H., Kimura, H., Hatano, S.-y., Suemori, H., Nakatsuji, N., Tada, T.
(2005). Octamer and Sox Elements Are Required for Transcriptional cis Regulation of Nanog Gene Expression. Mol. Cell. Biol.
25: 2475-2485
[Abstract]
[Full Text]
-
Alazard, R., Blaud, M., Elbaz, S., Vossen, C., Icre, G., Joseph, G., Nieto, L., Erard, M.
(2005). Identification of the 'NORE' (N-Oct-3 responsive element), a novel structural motif and composite element. Nucleic Acids Res
33: 1513-1523
[Abstract]
[Full Text]
-
Shirai, T., Miyagi, S., Horiuchi, D., Okuda-Katayanagi, T., Nishimoto, M., Muramatsu, M., Sakamoto, Y., Nagata, M., Hagiwara, K., Okuda, A.
(2005). Identification of an Enhancer That Controls Up-regulation of Fibronectin during Differentiation of Embryonic Stem Cells into Extraembryonic Endoderm. J. Biol. Chem.
280: 7244-7252
[Abstract]
[Full Text]
-
Okumura-Nakanishi, S., Saito, M., Niwa, H., Ishikawa, F.
(2005). Oct-3/4 and Sox2 Regulate Oct-3/4 Gene in Embryonic Stem Cells. J. Biol. Chem.
280: 5307-5317
[Abstract]
[Full Text]
-
Rao, R. R., Stice, S. L.
(2004). Gene Expression Profiling of Embryonic Stem Cells Leads to Greater Understanding of Pluripotency and Early Developmental Events. Biol. Reprod.
71: 1772-1778
[Abstract]
[Full Text]
-
O'Shea, K. S.
(2004). Self-renewal vs. Differentiation of Mouse Embryonic Stem Cells. Biol. Reprod.
71: 1755-1765
[Abstract]
[Full Text]
-
Pera, M. F., Trounson, A. O.
(2004). Human embryonic stem cells: prospects for development. Development
131: 5515-5525
[Abstract]
[Full Text]
-
Tanaka, S., Kamachi, Y., Tanouchi, A., Hamada, H., Jing, N., Kondoh, H.
(2004). Interplay of SOX and POU Factors in Regulation of the Nestin Gene in Neural Primordial Cells. Mol. Cell. Biol.
24: 8834-8846
[Abstract]
[Full Text]
-
Rajaram, N., Kerppola, T. K.
(2004). Synergistic Transcription Activation by Maf and Sox and Their Subnuclear Localization Are Disrupted by a Mutation in Maf That Causes Cataract. Mol. Cell. Biol.
24: 5694-5709
[Abstract]
[Full Text]
-
Miyagi, S., Saito, T., Mizutani, K.-i., Masuyama, N., Gotoh, Y., Iwama, A., Nakauchi, H., Masui, S., Niwa, H., Nishimoto, M., Muramatsu, M., Okuda, A.
(2004). The Sox-2 Regulatory Regions Display Their Activities in Two Distinct Types of Multipotent Stem Cells. Mol. Cell. Biol.
24: 4207-4220
[Abstract]
[Full Text]
-
Abeyta, M. J., Clark, A. T., Rodriguez, R. T., Bodnar, M. S., Pera, R. A. R., Firpo, M. T.
(2004). Unique gene expression signatures of independently-derived human embryonic stem cell lines. Hum Mol Genet
13: 601-608
[Abstract]
[Full Text]
-
Williams, D. C. Jr., Cai, M., Clore, G. M.
(2004). Molecular Basis for Synergistic Transcriptional Activation by Oct1 and Sox2 Revealed from the Solution Structure of the 42-kDa Oct1{middle dot}Sox2{middle dot}Hoxb1-DNA Ternary Transcription Factor Complex. J. Biol. Chem.
279: 1449-1457
[Abstract]
[Full Text]
-
Remenyi, A., Lins, K., Nissen, L. J., Reinbold, R., Scholer, H. R., Wilmanns, M.
(2003). Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers. Genes Dev.
17: 2048-2059
[Abstract]
[Full Text]
-
Wiebe, M. S., Nowling, T. K., Rizzino, A.
(2003). Identification of Novel Domains within Sox-2 and Sox-11 Involved in Autoinhibition of DNA Binding and Partnership Specificity. J. Biol. Chem.
278: 17901-17911
[Abstract]
[Full Text]
-
Lang, D., Epstein, J. A.
(2003). Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer. Hum Mol Genet
12: 937-945
[Abstract]
[Full Text]
-
Tokuzawa, Y., Kaiho, E., Maruyama, M., Takahashi, K., Mitsui, K., Maeda, M., Niwa, H., Yamanaka, S.
(2003). Fbx15 Is a Novel Target of Oct3/4 but Is Dispensable for Embryonic Stem Cell Self-Renewal and Mouse Development. Mol. Cell. Biol.
23: 2699-2708
[Abstract]
[Full Text]
-
Avilion, A. A., Nicolis, S. K., Pevny, L. H., Perez, L., Vivian, N., Lovell-Badge, R.
(2003). Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev.
17: 126-140
[Abstract]
[Full Text]
-
Fujikura, J., Yamato, E., Yonemura, S., Hosoda, K., Masui, S., Nakao, K., Miyazaki, J.-i., Niwa, H.
(2002). Differentiation of embryonic stem cells is induced by GATA factors. Genes Dev.
16: 784-789
[Abstract]
[Full Text]
-
Niwa, H., Masui, S., Chambers, I., Smith, A. G., Miyazaki, J.-i.
(2002). Phenotypic Complementation Establishes Requirements for Specific POU Domain and Generic Transactivation Function of Oct-3/4 in Embryonic Stem Cells. Mol. Cell. Biol.
22: 1526-1536
[Abstract]
[Full Text]
-
Ezashi, T., Ghosh, D., Roberts, R. M.
(2001). Repression of Ets-2-Induced Transactivation of the Tau Interferon Promoter by Oct-4. Mol. Cell. Biol.
21: 7883-7891
[Abstract]
[Full Text]
-
Kamachi, Y., Uchikawa, M., Tanouchi, A., Sekido, R., Kondoh, H.
(2001). Pax6 and SOX2 form a co-DNA-binding partner complex that regulates initiation of lens development. Genes Dev.
15: 1272-1286
[Abstract]
[Full Text]
-
Andersen, B., Rosenfeld, M. G.
(2001). POU Domain Factors in the Neuroendocrine System: Lessons from Developmental Biology Provide Insights into Human Disease. Endocr. Rev.
22: 2-35
[Abstract]
[Full Text]
-
Nowling, T. K., Johnson, L. R., Wiebe, M. S., Rizzino, A.
(2000). Identification of the Transactivation Domain of the Transcription Factor Sox-2 and an Associated Co-activator. J. Biol. Chem.
275: 3810-3818
[Abstract]
[Full Text]
-
Ambrosetti, D.-C., Scholer, H. R., Dailey, L., Basilico, C.
(2000). Modulation of the Activity of Multiple Transcriptional Activation Domains by the DNA Binding Domains Mediates the Synergistic Action of Sox2 and Oct-3 on the Fibroblast Growth Factor-4 Enhancer. J. Biol. Chem.
275: 23387-23397
[Abstract]
[Full Text]
-
Di Rocco, G., Gavalas, A., Popperl, H., Krumlauf, R., Mavilio, F., Zappavigna, V.
(2001). The Recruitment of SOX/OCT Complexes and the Differential Activity of HOXA1 and HOXB1 Modulate the Hoxb1 Auto-regulatory Enhancer Function. J. Biol. Chem.
276: 20506-20515
[Abstract]
[Full Text]